An in vitro study indicated that the downregulation of TSPAN1 significantly inhibited the proliferation and invasion of colon cancer cells, suggesting that TSPAN1 might be a valuable therapeutic target molecule in colon cancer (Chen et al., 2010). Here, TSPAN1 is linked to malignant colon neoplasm.